Skip to Content

News

January 6, 2017

Vezina invited to speak at American Society for Investigative Pathology annual meeting

Chad Vezina, PhD, will present “Linking DNA Methylation to Androgen Signaling and Prostate Proliferative Growth” at the 2017 American Society for Investigative Pathology (ASIP) annual meeting, held in conjunction with the 2017 Experimental Biology Meeting in Chicago, Illinois, April 22-26, 2017. His talk will take place during the session “Molecular and Cellular Basis of Disease Symposium: Epigenetics and Cancer.” View the ASIP_2017_Preliminary_Program.


December 7, 2016

SPUUR intern presents at NIDDK meeting

Leema John, 2016 SPUUR intern, presented her summer research findings at the 2016 NIDDK Urology Director’s Meeting in Pacific Grove, California, December 7-9, 2016.

2016_SPUUR_Intern_Leema_John_Presenting_at_NIDDK_Directors_Meeting_at_Asilomar_350


October 14, 2016

UMass Boston and Dana-Farber/Harvard Cancer Center U54 Partnership Receives $8.5M

The University of Massachusetts Boston and the Dana Farber/Harvard Cancer Center (DF/HCC) have been granted $8.5 million over five years from the National Institutes of Health to support their U54 Comprehensive Partnership for Cancer Disparities Research. UMass Boston and the DF/HCC have been in partnership for over 13 years, working together to end cancer disparities and train the next generation of cancer researchers.

The U54 partnership takes a two-pronged approach to cancer research. In addition to funding traineeships at the undergraduate, graduate, and post-graduate level for underrepresented minority students in the life sciences, the program funds research that seeks to address disparities in cancer care. Three research projects are already under way, and more will be added over the next five years.

Adán Colón-Carmona, associate professor of biology at UMass Boston, is principal investigator on the U54 partnership. Jill Macoska, director of the Center for Personalized Cancer Therapy (CPCT) at UMass Boston, is co-principal investigator. Dr. Macoska is a Project Leader with the University of Wisconsin & University of Massachusetts-Boston O’Brien Center for Benign Urologic Research.

Read the full news release here.


June 2016

Vezina presents lecture and talk at Cold Spring Harbor Laboratory course

Chad Vezina, PhD, gave a lecture and talk on prostate development and benign prostate disease at the" Cold Spring Harbor Lab Course, “Mouse Development, Stem Cells and Cancer,"":http://meetings.cshl.edu/courses.aspx?course=c-mous&year=16 held in Cold Spring Harbor, New York, June 8-28, 2016.


June 23, 2016

Jeong receives Department of Defense grant to study prostate disease development

Clara Jeong, PhD, received a Prostate Cancer Research Program Postdoctoral Training Award from the Department of Defense to support her investigation into the effects of environmental toxicants on prostate disease development. The two-year award begins June 30, 2016. Jeong is a postdoc trainee in the University of Wisconsin Molecular and Environmental Toxicology Center (METC) and a member of the Ricke lab.


April 29, 2016

Vezina receives Zoetis Animal Health Award for Research Excellence

Chad Vezina, PhD, associate professor of comparative biosciences in the UW School of Veterinary Medicine, is the recipient of the 2016 Zoetis Animal Health Award for Research Excellence. The UW School of Veterinary Medicine established the award in 1985 and it is given to those faculty members who, through their dedication and investigation in research, are chosen from among their peers as an outstanding researcher in the field of veterinary medicine.


April 11, 2016

Bushman receives VA grant to study link between prostate inflammation and BPH/LUTS

Wade Bushman, MD, PhD, the Robert F. and Dolores K. Schnoes Chair in Urologic Research, was recently awarded a 4-year Merit Award from the Veteran’s Administration to study the role of prostate inflammation in Benign Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS). Recent large clinical studies have revealed, unexpectedly, that prostate inflammation is strongly associated with LUTS in aging men and may be as important as prostate enlargement in producing the symptoms typically attributed to BPH.

In his project “Role of Inflammation and Fibrosis in Benign Prostatic Hyperplasia and Lower Urinary Tract Symptom,” Dr. Bushman and his colleagues will use a database of 300 patients who underwent detailed urodynamic evaluation prior to surgical treatment of BPH. The correlation of prostate inflammation with bladder function on urodynamic evaluation will be the first ever functional study of the effects of prostate inflammation. The studies are expected to make a significant impact on the understanding and treatment of BPH/LUTS in aging men and advance the ongoing effort to develop new and more effective treatments for patients with this condition.

Dale Bjorling, DVM, O’Brien Center co-director, is a co-investigator on the grant. The researchers will utilize the Rodent Urinary Function Testing Facility.


February 2016

Ricke named UWMF Professor of Urologic Research

William A. Ricke, PhD, associate professor in the Department of Urology, has been named the University of Wisconsin Medical Foundation Professor of Urologic Research. Dr. Ricke is the director of the O’Brien Center for Benign Urology Research.


December 15, 2015

Funding announcement for George M. O’Brien Urology Cooperative Research Centers Program

The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) is pleased to announce the release of a new Funding Opportunity Announcement (FOA) seeking applications for the George M. O’Brien Urology Cooperative Research Centers Program. Letters of Intent are due January 22, 2016. Application deadline is February 22 by 5:00 p.m. local time of applicant organization. This program will provide a coordinated platform for multidisciplinary interactions between basic and clinical scientists with the overall goal of understanding the etiology and development of benign urologic diseases and disorders, and providing a collaborative venue to design better treatments, diagnostics, and prevention strategies for these disease conditions within the NIDDK mission interests. This program will also serve as a national resource to the larger urological research community and provide educational enrichment opportunities to scientists electing to pursue research in benign urology. Accordingly, applications are sought from individuals willing to cooperate with the NIDDK under a cooperative centers program. The funded Centers will work with the NIDDK in facilitating research collaborations and interactions within and among centers and with the larger research community to accomplish the overall goal of improving treatment of urologic disorders through enhanced communication and research excellence. View the full announcement on the NIH website. For more information about this funding announcement, please email Dr. Deborah Hoshizaki.


December 7, 2015

Paul Marker presents prostate cancer talk at University of Massachusetts Boston

Paul Marker, PhD, professor and associate dean for research at the University of Wisconsin-Madison School of Pharmacy, presented “Identifying molecular mechanisms of prostate cancer using transposon-mediated mutagenesis and mouse models” at the University of Massachusetts Boston on December 7, 2015. The talk was hosted by the Personalized Cancer Therapy Center as part of its Fall Seminar Series. View flyer for the Paul_Marker_presentation.


December 7, 2015

Funding announcement for the Developmental Centers for Interdisciplinary Research in Benign Urology (P20)

The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) is pleased to announce a new Funding Opportunity Announcement (FOA) to seek applications for the Developmental Centers for Interdisciplinary Research in Benign Urology Program (P20). The intent of this Program is to build research teams composed of individuals with complementary expertise who propose to develop innovative resources or new research projects that utilize integrative approaches addressing research questions relevant to benign urological diseases. Application due date is February 22, 2016. Please be advised that, although not required, a letter of intent is strongly encouraged to be received by KUH by January 22, 2016. The full funding opportunity announcement can be viewed online.. To request additional information, please contact Dr. Deborah Hoshizaki.


November 12, 2015

Velky and Thomas receive travel awards to attend SBUR Fall Meeting

The Society of Basic Urologic Research (SBUR) awarded Jordan Velky and Sam Thomas, pre-doctoral trainees in the Ricke lab, 2015 Travel Awards to attend the SBUR Fall Symposium July 12-15, 2015, in Fort Lauderdale, Florida. The theme for the symposium is “The Environment-Gene Interface in Urologic Health and Disease.”


September 18, 2015

Boston Business Journal names Macoska ‘Woman to Watch’

Jill A. Macoska, PhD, Alton J. Brann Distinguished Professor of Science and Mathematics, professor of biological sciences, and director of the Center for Personalized Cancer Therapy at The University of Massachusetts, Boston, was named to Boston Business Journal’s 2015 Women to Watch list. The list of 20 women from the science and technology sectors where chosen for their work in making a difference in the local economy while blazing a path for future women to follow.


February 6, 2015

Ricke meets with urologic scientists at Clark-Atlanta University

William Ricke, PhD, director of the O’Brien Center for Benign Urologic Research, was visiting professor at Clark-Atlanta University where he presented “Hormone Action and Paracrine Effects in the Prostate.” Dr. Ricke spent the day visiting with graduate students and postdocs from the Department of Biological Sciences.


webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System